Centre Hospitalier Universitaire de Besancon — Besançon

Public research footprint of Centre Hospitalier Universitaire de Besancon, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus, Type 2 · Breast Cancer Stage II · Squamous Cell Carcinoma of Anal Canal · Non-small Cell Lung Cancer Metastatic

Recently updated registry entries

NCT05259033 — A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination… (Completed)
NCT03695978 — Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated &… (Recruiting)
NCT07237256 — Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre Hospitalier Universitaire de Besancon?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.